Fig. 2 | npj Breast Cancer

Fig. 2

From: Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

Fig. 2

OncotypeDX score plotted against metabolomic Random Forest (RF) score. The predicted outcome based on the TAILORx-defined recurrence score classification (low/intermediate/high), sub-stratified by nuclear magnetic resonance (NMR) metabolomic RF risk score (low/high), compared to actual patient outcomes (recurrences denoted in red). The dashed line represents the cut-off for the metabolomic RF score optimised in this dataset

Back to article page